1-10 of 10
Peter J. Wild
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma

Kathrin Oehl, Bart Vrugt, Ulrich Wagner, Michaela B. Kirschner, Mayura Meerang, Walter Weder, Emanuela Felley-Bosco, Bernd Wollscheid, Katrin Bankov, Melanie C. Demes, Isabelle Opitz, Peter J. Wild
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (8): 2277–2291.
https://doi.org/10.1158/1078-0432.CCR-20-4037
Published: 15 April 2021
View article titled, Alterations in <em>BAP1</em> Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma
Open the PDF for Alterations in <em>BAP1</em> Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy

Helle Kristensen, Christa Haldrup, Siri Strand, Kamilla Mundbjerg, Martin M. Mortensen, Kasper Thorsen, Marie Stampe Ostenfeld, Peter J. Wild, Christian Arsov, Wolfgang Goering, Tapio Visakorpi, Lars Egevad, Johan Lindberg, Henrik Grönberg, Søren Høyer, Michael Borre, Torben F. Ørntoft, Karina D. Sørensen
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (8): 2169–2181.
https://doi.org/10.1158/1078-0432.CCR-13-2642
Published: 15 April 2014
View article titled, Hypermethylation of the <em>GABRE∼miR-452∼miR-224</em> Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
Open the PDF for Hypermethylation of the <em>GABRE∼miR-452∼miR-224</em> Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy in another window
Includes: Supplementary data
Journal Articles

Expression of Serotonin Receptors in Human Hepatocellular Cancer

Christopher Soll, Marc-Oliver Riener, Christian Eugen Oberkofler, Claus Hellerbrand, Peter J. Wild, Michelle L. DeOliveira, Pierre-Alain Clavien
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (21): 5902–5910.
https://doi.org/10.1158/1078-0432.CCR-11-1813
Published: 06 November 2012
View article titled, Expression of Serotonin Receptors in Human Hepatocellular Cancer
Open the PDF for Expression of Serotonin Receptors in Human Hepatocellular Cancer in another window
Journal Articles

KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy

Ashkan Mortezavi, Thomas Hermanns, Hans-Helge Seifert, Martin K. Baumgartner, Maurizio Provenzano, Tullio Sulser, Maximilian Burger, Matteo Montani, Kristian Ikenberg, Ferdinand Hofstädter, Arndt Hartmann, Rolf Jaggi, Holger Moch, Glen Kristiansen, Peter J. Wild
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (5): 1111–1121.
https://doi.org/10.1158/1078-0432.CCR-10-0081
Published: 01 March 2011
View article titled, KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy
Open the PDF for KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy in another window
Includes: Supplementary data
Journal Articles

Loss of VHL and Hypoxia Provokes PAX2 Up-Regulation in Clear Cell Renal Cell Carcinoma

Van-Duc Luu, Gunther Boysen, Kirsten Struckmann, Silvia Casagrande, Adriana von Teichman, Peter J. Wild, Tullio Sulser, Peter Schraml, Holger Moch
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3297–3304.
https://doi.org/10.1158/1078-0432.CCR-08-2779
Published: 18 May 2009
View article titled, Loss of VHL and Hypoxia Provokes PAX2 Up-Regulation in Clear Cell Renal Cell Carcinoma
Open the PDF for Loss of VHL and Hypoxia Provokes PAX2 Up-Regulation in Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

HER3 Is a Determinant for Poor Prognosis in Melanoma

Markus Reschke, Daniela Mihic-Probst, Edward Htun van der Horst, Pjotr Knyazev, Peter J. Wild, Markus Hutterer, Stefanie Meyer, Reinhard Dummer, Holger Moch, Axel Ullrich
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5188–5197.
https://doi.org/10.1158/1078-0432.CCR-08-0186
Published: 12 August 2008
View article titled, HER3 Is a Determinant for Poor Prognosis in Melanoma
Open the PDF for HER3 Is a Determinant for Poor Prognosis in Melanoma in another window
Includes: Supplementary data
Journal Articles

Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy

Raihanatou Diallo-Danebrock, Evelyn Ting, Oleg Gluz, Alexander Herr, Svjetlana Mohrmann, Helene Geddert, Achim Rody, Karl-Ludwig Schaefer, Stephan E. Baldus, Arndt Hartmann, Peter J. Wild, Michael Burson, Helmut E. Gabbert, Ulrike Nitz, Christopher Poremba
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (2): 488–497.
https://doi.org/10.1158/1078-0432.CCR-06-1842
Published: 25 January 2007
View article titled, Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy
Open the PDF for Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer

Edgar Dahl, Glen Kristiansen, Kathrin Gottlob, Irina Klaman, Elke Ebner, Bernd Hinzmann, Klaus Hermann, Christian Pilarsky, Matthias Dürst, Monika Klinkhammer-Schalke, Hagen Blaszyk, Ruth Knuechel, Arndt Hartmann, André Rosenthal, Peter J. Wild
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (13): 3950–3960.
https://doi.org/10.1158/1078-0432.CCR-05-2090
Published: 03 July 2006
View article titled, Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer
Open the PDF for Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer in another window
Journal Articles

Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder

Peter J. Wild, Alexander Herr, Christoph Wissmann, Robert Stoehr, Andre Rosenthal, Dirk Zaak, Ronald Simon, Ruth Knuechel, Christian Pilarsky, Arndt Hartmann
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4415–4429.
https://doi.org/10.1158/1078-0432.CCR-05-0259
Published: 15 June 2005
View article titled, Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder
Open the PDF for Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder in another window
Includes: Supplementary data
Journal Articles

Microsatellite Instability Predicts Poor Short-Term Survival in Patients with Advanced Breast Cancer after High-Dose Chemotherapy and Autologous Stem-Cell Transplantation

Peter J. Wild, Albrecht Reichle, Reinhard Andreesen, Georg Röckelein, Wolfgang Dietmaier, Josef Rüschoff, Hagen Blaszyk, Ferdinand Hofstädter, Arndt Hartmann
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (2): 556–564.
https://doi.org/10.1158/1078-0432.CCR-0601-03
Published: 03 February 2004
View article titled, Microsatellite Instability Predicts Poor Short-Term Survival in Patients with Advanced Breast Cancer after High-Dose Chemotherapy and Autologous Stem-Cell Transplantation
Open the PDF for Microsatellite Instability Predicts Poor Short-Term Survival in Patients with Advanced Breast Cancer after High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in another window
Includes: Supplementary data